The Ayers Institute for Pre-cancer Detection and Diagnosis was established on July 1, 2005 at Vanderbilt University Medical Center.  The objectives of the Ayers Institute are as follows:

  • To detect cancers and pre-cancers at their earliest stages
  • To develop diagnostic tests to assess the prognosis for cancers and to predict responses to cancer treatment
  • To advance the science and technology of cancer detection and diagnosis.

Led by Daniel Liebler, Ph.D., the Ayers Institute applies new proteomics technologies to identify protein biomarkers for cancer.  Vanderbilt is recognized worldwide for leadership in proteomics technologies.  The Ayers Institute brings together a research team spanning basic and clinical research disciplines to advance the science behind new diagnostics to save lives and prevent suffering due to cancer.

For further information, please visit
The Ayers Institute at Vanderbilt-Ingram Cancer Center